Sign up to be contacted when the study resumes
HerediGene: Population Study is a large-scale collaboration between Intermountain Healthcare and deCODE genetics focused on discovering new connections between genetics and human disease.
Teams from the two organizations will analyze the complete DNA of 500,000 participants from Intermountain’s patient population to help medical professionals better understand the human genome and enhance their ability to prevent diseases such as breast cancer, colon cancer, and heart disease. The collaboration combines Intermountain’s internationally-recognized expertise in precision medicine and clinical care with deCODE’s world-class expertise in human population genetics. The project will be the largest and most comprehensive DNA mapping effort to date in the U.S. from a single population.
To speak to a member of our team or for additional inquiries, call us at 1-833-698-1727 or email email@example.com.
Participation in the HerediGene: Population Study has been temporarily suspended in response to coronavirus (COVID-19). Sign up here to be notified when the study resumes at the following locations:
Get Care Now
Get care for low-level urgent conditions through a video chat with a provider, 24/7, on your computer or mobile device.Learn More.
View wait times and save your place in line at an Intermountain InstaCare location near you.
If this is an emergency please go to the nearest emergency room or call 911.
Intermountain Healthcare is a Utah-based, not-for-profit system of 24 hospitals (includes "virtual" hospital), a Medical Group with more than 2,400 physicians and advanced practice clinicians at about 160 clinics, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in clinical quality improvement and efficient healthcare delivery.
Still not finding what you are looking for?
Copyright ©2020, Intermountain Healthcare, All rights reserved.